BDP Week Featured Sessions: Improve Your Understanding of Biopharmaceutical Raw Material Variability

Mitigating risk of raw material variability and managing the quality of raw materials is crucial for biopharmaceutical drug developers to maintain the integrity of their process and product. Today's featured sessions in  Improve Your Understanding of Biopharmaceutical Raw Material Variability will provide examples of critical raw materials and strategies for raw material testing to help you understand lot-to-lot variability. It will also provide strategies for raw material characterization and control to improve your production processes.

A few of the top session at Biopharmaceutical Development and Process Week that look directly at this topic are:

• Challenges with Performance Testing of Raw Materials
• Baochuan Huang, Principal Engineer, Shire Pharmaceuticals
• CASE STUDY Predicting mAb Product Yields from Fused PAT Data: Assessing, Quantifying and Understanding Lot-to-Lot Variability of mAb Media Components
• Jose C. Menezes, Ph.D., Professor, Institute for Biotechnology and Bioengineering, Technical University of Lisbon, Portugal
• CASE STUDY Raw Material Impurities and the Impact on Media Variability
• Chandana Sharma, Ph.D., Principal Scientist, Cell Sciences and Development, SAFC

Biopharmaceutical Development and Process Week will take place February 25-March 1, 2013 in Huntington Beach, California.  All sessions focusing on Raw Materials will take place Monday, February 25 and Tuesday, February 26.  For more information about these sessions and the rest of the agenda, download the brochure here.  If you'd like to register to join us, mention code BDP13JP you'll save 20% off the standard rate!  If you have any questions about this event, feel free to reach out to email Jennifer Pereira.

Share this article with your social network, just click below to share now!

Share |